Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

8:26
 
Share
 

Manage episode 410134238 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.

(00:33)
Do you mind giving us a brief introduction of yourself and what you do at Mayo?

(01:45)
Can you tell us a little about the test and how it came to be?

(03:00)
Could you explain the types of patients this test would be best suited for and how a provider might determine if their patient would benefit from this?

(03:32)
Would you please explain why the algorithm is recommended and where in the algorithm this test fits?

(04:36)
What makes this test different from what's currently available to providers?

(05:38)
How can the information be used in patient care? And can you talk a little bit about how the diagnosis can be clarified by using this assay, why it's important, and how the results would impact a patient's care and treatment plan?

  continue reading

308 episodes

Artwork
iconShare
 
Manage episode 410134238 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.

(00:33)
Do you mind giving us a brief introduction of yourself and what you do at Mayo?

(01:45)
Can you tell us a little about the test and how it came to be?

(03:00)
Could you explain the types of patients this test would be best suited for and how a provider might determine if their patient would benefit from this?

(03:32)
Would you please explain why the algorithm is recommended and where in the algorithm this test fits?

(04:36)
What makes this test different from what's currently available to providers?

(05:38)
How can the information be used in patient care? And can you talk a little bit about how the diagnosis can be clarified by using this assay, why it's important, and how the results would impact a patient's care and treatment plan?

  continue reading

308 episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide